GlassScriptPhysician profile
Jerry S Garrett
NPI 1427060425
$359.74
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.76 · 2020: $64.44 · 2021: $186 · 2022: $40.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $76.20 | 2021 | |
| Dendreon Pharmaceuticals LLC | $64.36 | 2019-2021 | |
| Myovant Sciences INC. | $42.82 | 2021 | |
| Baxter Healthcare | $40.50 | 2022 | |
| Boston Scientific Corporation | $31.72 | 2020 | |
| Richard Wolf Medical Instruments Corp. | $25.13 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $23.79 | 2021 | |
| Allergan, INC. | $23.30 | 2019 | |
| Blue Earth Diagnostics | $20.25 | 2021 | |
| Pfizer INC. | $11.67 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.